Christopher Gerry

President and Principal Executive Officer at Sensei Biotherapeutics.

Raised on Sensei Biotherapeutics filings

$348.9M

of $348.9M offered across 1 Form D filing

Company

Biotech · Rockville, MD

Targeted drug for endometrial and breast cancer

Targeted drug for endometrial and breast cancer

Sensei Biotherapeutics Form D filings
Filed	Security	Sold of offered	Filing
Mar 4, 2026	Equity	$348.9M/ $348.9M	Form D

Also named on Sensei Biotherapeutics filings